Strengthening of Rotator Cuff and Scapular Muscles in Patients With Lateral Elbow Tendinopathy: A Randomized Controlled Study.

Arch Phys Med RehabilMay 22, 2026 (epub)
Clinical ResearchPhysical Medicine & Rehabilitation

Pelin Tiryaki, Derya Çelik

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the effects of scapular and rotator cuff muscle strengthening exercises in conjunction with an elbow-focused rehabilitation program for patients with lateral elbow tendinopathy (LET). The study involved 58 participants aged 18 to 65 years. Results indicated a significant improvement in the Patient-Rated Tennis Elbow Evaluation (PRTEE) score, with a mean difference of -13.06 at the 1-year follow-up.

Key findings

  • Mean difference in PRTEE score between groups was -13.06 at 1-year follow-up.
  • Significant group-by-time interaction for NPRS-activity and NPRS-rest (P<.05).
  • Improvements noted in maximum and pain-free grip strength and pressure pain threshold.
  • Strength of rotator cuff and scapular muscles significantly improved in the intervention group.

Why it matters

Incorporating scapular and rotator cuff strengthening into rehabilitation for lateral elbow tendinopathy may enhance patient outcomes, addressing both pain and functional limitations more effectively than wrist extensor exercises alone.

Source

PubMed · PMID 42177007

Published in Arch Phys Med Rehabil. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Physical Medicine & Rehabilitation

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.